Next Meetings

Spinal Muscular Atrophy

New England CEPAC
March 7, 2019 10am-4pm ET

Omni Parker House
60 School Street
Boston, MA 02108

The New England CEPAC will convene to deliberate and vote on ICER's report on treatments for SMA.


May 23, 2019 9am- 5pm CT

Hyatt Regency O’Hare
9300 Bryn Mawr Avenue
Rosemont, IL 60018

The Midwest CEPAC will convene to review evidence on esketamine as a therapy for treatment-resistant depression. The Council will also review a report on siponimod for treatment of secondary progressive MS during this meeting.


Multiple Sclerosis

Midwest CEPAC
May 23, 2019 9am-5pm CT

Hyatt Regency O’Hare
9300 Bryn Mawr Avenue
Rosemont, IL 60018

The Midwest CEPAC will convene to review ICER's assessment of siponimod (Novartis) for secondary progressive multiple sclerosis.


June 11, 2019 10AM-4PM

California Endowment Oakland Conference Center
2000 Franklin St.
Oakland, CA 94612

CTAF will convene to review ICER's assessment of treatments for peanut allergy.


Duchenne Muscular Dystrophy

New England CEPAC
July 25, 2019 10am-4pm ET

Boston, MA

The New England CEPAC will convene to deliberate and vote on evidence presented in ICER's report on treatments for Duchenne muscular dystrophy.


past Meetings

Sep 2018
Midwest CEPAC

Amyloidosis

The Midwest CEPAC deliberated and voted on ICER's report on treatments for hereditary transthyretin-related (hATTR) amyloidosis, a rare genetic condition characterized by nerve, heart, and eye damage that is currently treated through supportive measures alone. The Council also reviewd a report on therapies for prostate cancer during this meeting.